EKF signs DiaSpect Tm U.S. distribution agreement with McKesson
EKF Diagnostics recently announced that it had signed a private label distribution agreement with McKesson Medical-Surgical Inc. for the Company’s hand-held reagent-free hemoglobin analyser, the DiaSpect Tm. McKesson is the oldest and largest healthcare company in the U.S., serving more than 50% of U.S. hospitals and 20% of physicians. The DiaSpect Tm is the world’s fastest hemoglobin analyser and is sold in the U.S. since February 2019 by McKesson under its own branded line, as the McKesson Consult® Hb analyser. The palm-sized, lightweight DiaSpect Tm provides users in a variety of care settings with laboratory accurate hemoglobin measurements (precision: CV ≤1%) within two seconds of its whole blood-filled cuvette being inserted for analysis. This ensures immediate and robust hemoglobin results for patient health checks and anemia screening at the point of care. Based on its FDA categorization, DiaSpect Tm can be used in a range of environments, as well as by a broad scope of healthcare personnel. Essential for this, it is highly user-friendly requiring minimal training. For example, the analyser’s sampling microcuvette has been designed to collect a blood sample from any angle without forming air bubbles. The user simply collects a capillary or venous blood sample of 10 µL in the cuvette before inserting straight into the analyser. Also making it simple for POCT use, DiaSpect Tm is factory calibrated against the HiCN reference method in accordance with ICSH. It is ‘always on’ and ready to use with no re-calibration or maintenance necessary.